Boston Scientific Recalls Nalu TD2 Therapy Discs Due to Firmware Issue
Boston Scientific is recalling certain Nalu TD2 Therapy Discs and Patient Kits due to a firmware error that can disrupt pain therapy.
Boston Scientific Neuromodulation Corporation is recalling 134 units of its Nalu TD2 Therapy Disc with firmware and TD2 Patient Kit, which are part of the Nalu Neurostimulation System.
A firmware defect can cause the Therapy Disc to repeatedly attempt to restart and ultimately fail, rendering it non-functional. If a secondary Therapy Disc is unavailable, the Implantable Pulse Generator cannot function properly, leaving the system unable to inhibit pain signals.
The recalled medical devices were distributed nationwide across Pennsylvania, Florida, Oregon, Arizona, Ohio, South Carolina, Texas, Oklahoma, Michigan, California, and New Jersey. The action is classified as a Class II recall by the U.S. Food and Drug Administration (FDA).
What to do
- Stop using the affected Therapy Disc if instructed by your physician or if the device becomes non-functional.
- Switch to a secondary or backup Therapy Disc if one is available to maintain therapy.
- Contact Boston Scientific Neuromodulation Corporation or your healthcare provider for assistance.
- Report any adverse events or device malfunctions to the FDA.
At a glance
| Agency | U.S. Food and Drug Administration (FDA) |
|---|---|
| Recall number | Z-0311-2027 |
| Date | 2026-11-04 |
| Company | Boston Scientific Neuromodulation Corporation, Valencia, CA |
| Severity | Class II |
| Quantity | 134 |
| Where sold | US Nationwide distribution in the states of PA, FL, OR, AZ, OH, SC, TX, OR, OK, MI, CA, NJ. |
| Lot codes / identifiers | Firmware versions v2.0.71 and v2.0.77 REF/UDI-DI/Serial Numbers: 34014-001/00812537037134/ 100855, 100877, 100883, 100884, 100886, 100888, 100898, 100903, 100908, 100911, 100916, 100932, 101103, 100902; 74011/00812537037127, 00812537036977/101439, 100913, 100949, 101159, 101162, 101163, 101164, 101173, 101175, 101177, 101186, 101187, 101188, 101189, 101192, 101200, 101205, 101208, 101213, 101214, 101218, 101219, 101221, 101222, 101240, 101245, 101247, 101249, 101256, 101257, 101259, 101260, 101261, 101264, 101267, 101268, 101270, 101272, 101273, 101277, 101278, 101280, 101283, 101284, 101290, 101297, 101298, 101301, 101305, 101307, 101310, 101311, 101312, 101314, 101315, 101326, 101330, 101331, 101334, 101338, 101344, 101345, 101346, 101356, 101357, 101358, 101359, 101363, 101364, 101367, 101375, 101376, 101377, 101378, 101381, 101383, 101387, 101388, 101392, 101400, 101405, 101408, 101410, 101414, 101415, 101417, 101418, 101419, 101429, 101431, 101432, 101436, 101440, 101441, 101443, 101447, 101448, 101450, 101451, 101466, 101490, 101493, 101504, 101510, 101511, 101514, 101520, 101527, 101528, 101534, 101535, 101553, 101557, 101567, 101571, 101576, 101599, 101617, 101623, 101656 |
Source: official FDA notice. This summary was written by 365 News from the official notice. Details can change; check the notice before acting.